Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saber Ebrahimi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physiology & Behavior|June 28, 2025
Orexin-A and BDNF in the hippocampus of middle-aged rats: beneficial effects of integrating voluntary physical activity with intermittent fastingMohammad Saber Ebrahimi, Mansoureh Ahmadpour, Shaghayegh Modaberi, et al.
Cancer Gene Therapy|March 16, 2026
Memory programming and new manufacturing paradigms in CAR-T cell therapyNiloufar Mohammadkhani, Saber Ebrahimi, Marzieh Hesam Mohammadi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 16, 2015
Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cellsMajid Safa, Behnaz Tavasoli, Rima Manafi, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 12, 2025
Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engagerSaber Ebrahimi, Benedikt J Lohnes, Shamsul A Khan, et al.
International Journal of Molecular Sciences|September 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and MelanomaSedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physiology & Behavior|June 28, 2025
Orexin-A and BDNF in the hippocampus of middle-aged rats: beneficial effects of integrating voluntary physical activity with intermittent fastingMohammad Saber Ebrahimi, Mansoureh Ahmadpour, Shaghayegh Modaberi, et al.
Cancer Gene Therapy|March 16, 2026
Memory programming and new manufacturing paradigms in CAR-T cell therapyNiloufar Mohammadkhani, Saber Ebrahimi, Marzieh Hesam Mohammadi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 16, 2015
Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cellsMajid Safa, Behnaz Tavasoli, Rima Manafi, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 12, 2025
Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engagerSaber Ebrahimi, Benedikt J Lohnes, Shamsul A Khan, et al.
International Journal of Molecular Sciences|September 13, 2025
CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and MelanomaSedigheh Givi, Benedikt J Lohnes, Saber Ebrahimi, et al.
Pageof 1